This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Save to my personal folders Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Toh, C.-K. Articles by Tan, E.-H. Search for Related Content PubMed PubMed Citation Articles by Toh, C.-K. Articles by Tan, E.-H. Related Articles Related Correspondence

Never-Smokers With Lung Cancer: Epidemiologic Evidence of a Distinct Disease Entity

Chee-Keong Toh, Fei Gao, Wan-Teck Lim, Swan-Swan Leong, Kam-Weng Fong, Swee-Peng Yap, Anne A.L. Hsu, Philip Eng, Heng-Nung Koong, Agasthian Thirugnanam, Eng-Huat Tan

From the Department of Medical Oncology; Division of Clinical Trials and Epidemiological Sciences; Department of Therapeutic Radiology; Department of Surgical Oncology, National Cancer Centre; and the Department of Respiratory and Critical Care Medicine, Singapore General Hospital, Singapore, Singapore.

Address reprint requests to Chee-Keong Toh, MD, Department of Medical Oncology, National Cancer Centre, 11 Hospital Dr, Singapore, Singapore 169610; e-mail: dmotck{at}nccs.com.sg

PURPOSE: Tobacco smoke is a definite causative agent for lung cancer. It is increasingly being recognized that never-smokers can be afflicted with non–small-cell lung cancer (NSCLC). We aim to assess survival differences between smokers and never-smokers with NSCLC.

PATIENTS AND METHODS: We analyzed 975 NSCLC patients who presented from January 1999 to December 2002. Clinical characteristics among current-, former- and never-smokers were tested using ² or Kruskal-Wallis test. The hazard ratio (HR) for death and its 95% CI were calculated by Cox regression.

RESULTS: Of 975 patients, 59 had no smoking history and 33 had no quit time recorded. Of 883 patients analyzed, 286 patients (32.4%) were never-smokers. One hundred ninety-six never-smokers (68.5%) were females compared with 12% among current- and 13% among former-smokers (P < .001). There was a significant difference in histologic subtype between never-smokers and smokers: 69.9% with adenocarcinoma versus 39.9% (current-smokers) versus 47.3% (former-smokers); 5.9% with squamous cell carcinoma versus 35.7% (current-smokers) versus 28% (former-smokers; P < .001). Smokers had significantly poorer performance status (P = .002) and higher median age at diagnosis (P < .001) while more never-smokers presented with advanced disease (P = .002). Eight hundred and five patients (82.6%) died by May 30, 2005. The HR for smokers was significantly higher on both univariate and multivariate analysis (HR, 1.297; 95% CI, 1.040 to 1.619).

CONCLUSION: Never-smokers comprised a high proportion of NSCLC patients in Singapore. Definite epidemiologic differences exist between never-smokers and smokers. Differences in survival outcome further suggest that the biology underlying the pathogenesis and behavior of the disease may be different for never-smokers.

Presented in part at the 11th World Conference on Lung Cancer, Barcelona, Spain, July 3-6, 2005.

Authors' disclosures of potential conflicts of interest and author contributions are found at the end of this article.

Related Correspondence

• Effects of Comorbidity and Smoking on the Survival of Lung Cancer Patients
  Jeong-Seon Ryu and Hun-Jae Lee
  JCO 2006 24: 5468-5469 [Full Text]

This article has been cited by other articles:

				I. I. Na, B. H. Byun, H. J. Kang, G. J. Cheon, J. S. Koh, C. H. Kim, D. H. Choe, B.-Y. Ryoo, J. C. Lee, S. M. Lim, et al. 18F-Fluoro-2-Deoxy-Glucose Uptake Predicts Clinical Outcome in Patients with Gefitinib-Treated Non-Small Cell Lung Cancer Clin. Cancer Res., April 1, 2008; 14(7): 2036 - 2041. [Abstract] [Full Text] [PDF]

				F. Ciardiello and G. Tortora EGFR Antagonists in Cancer Treatment N. Engl. J. Med., March 13, 2008; 358(11): 1160 - 1174. [Full Text] [PDF]

				C.-K. Toh and W.-T. Lim Lung cancer in never-smokers J. Clin. Pathol., April 1, 2007; 60(4): 337 - 340. [Full Text] [PDF]

				J. Subramanian and R. Govindan Lung Cancer in Never Smokers: A Review J. Clin. Oncol., February 10, 2007; 25(5): 561 - 570. [Abstract] [Full Text] [PDF]

				J.-S. Ryu and H.-J. Lee Effects of Comorbidity and Smoking on the Survival of Lung Cancer Patients J. Clin. Oncol., December 1, 2006; 24(34): 5468 - 5469. [Full Text] [PDF]

				C.-K. Toh, W.-T. Lim, S.-S. Leong, and E.-H. Tan In Reply J. Clin. Oncol., December 1, 2006; 24(34): 5469 - 5469. [Full Text] [PDF]

				C. M. Nagle, C. J. Bain, and P. M. Webb Cigarette Smoking and Survival after Ovarian Cancer Diagnosis Cancer Epidemiol. Biomarkers Prev., December 1, 2006; 15(12): 2557 - 2560. [Abstract] [Full Text] [PDF]